Patents
Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
06/2001
06/19/2001US6248755 Antiinflammatory agents; antiallergens; autoimmune diseases
06/14/2001WO2001027111A3 Bicyclic imidazo-3-yl-amine derivatives
06/14/2001WO2001002373A8 Dihydrobenzodiazepins and their use for treating dyslipidemia
06/13/2001EP0656892B1 Herbicidal 2- (4-heterocyclic-phenoxymethyl)phenoxy]-alkanoates
06/12/2001US6245871 Group 8-10 transition metal olefin polymerization catalysts
06/12/2001US6245796 Tricyclic pyrrole or pyrazole derivative
06/12/2001US6245776 Drug mixture of immune response modifier, fatty acid, preservative and carbomer
06/12/2001US6245449 Material for organoelectroluminescence device and use thereof
06/07/2001WO2001040185A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation
06/07/2001WO2000069424A3 Method of treating psychotic disorders
06/07/2001DE19948436A1 New azolo-fused bicyclic imidazolyl-amine compounds, useful as alpha-2 adrenergic receptor ligands and analgesics
06/07/2001DE19948434A1 Substanzbibliothek enthaltend bicyclische Imidazo-5-amine und/oder bicyclische Imidazo-3-amine Substance library containing bicyclic imidazo-5-amines and / or bicyclic imidazo-3-amine
06/07/2001CA2389368A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation
06/06/2001EP1104425A1 Novel thiazolopyrimidine compounds
06/06/2001EP0737188B1 Arthropodicidal oxadiazine carboxanilides
06/06/2001EP0681584B1 Condensed heterocyclic glutamic acid derivatives as antiproliferative agents
06/06/2001CN1298398A 12,13-modified epothilone derivatives
06/05/2001US6242471 Bone disorders, osteoporosis, rheumatoid arthritis, arteriosclerosis, cancer metastasis, nervous system and brain disorders
06/05/2001US6242441 Use of brinzolamide to prevent visual field loss
06/05/2001CA2047848C Azabicyclo derivatives
05/2001
05/30/2001EP0672043B1 Novel 4-(3-benzofuranyl)piperidinyl and 4-(3-benzothienyl)piperidinyl derivatives and pharmaceutical compositions containing them
05/29/2001US6239175 Carbamoyloxy derivatives of mutiline and their use as antibacterials
05/29/2001US6239129 Characterised by an indole ring on the aromatic moiety by a cyano group and on the indole nitrogen by an aminoalkyl chain. great affinity for 5-ht2c receptors, useful for depression, panic attacks, obsessive-compulsive disorders, phobias,
05/25/2001WO2001036426A1 Pyridinones to treat and prevent bacterial infections
05/25/2001WO2001036425A2 Imidazole compounds used as phosphodiesterase vii inhibitors
05/25/2001WO2001036408A1 Compounds with antibacterial and antiparasitic properties
05/25/2001WO1999033841B1 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha-1-blocking action
05/25/2001CA2391087A1 Imidazole compounds as phosphodiesterase vii inhibitors
05/25/2001CA2390658A1 Pyridinones to treat and prevent bacterial infections
05/23/2001EP1100805A1 Medicine nitrate salts
05/23/2001EP1100803A2 Pyrrolo 2,1-b] 1,3]benzothiazepines with atypical antipsychotic activity
05/23/2001EP1100802A1 OXAZOLO, THIAZOLO AND SELENAZOLO [4,5-c]-QUINOLIN-4-AMINES AND ANALOGS THEREOF
05/23/2001EP1100779A1 Substituted indolinones, the production thereof and their use as medicaments
05/23/2001EP1100504A2 Pharmaceutical compositions and their uses for treatment of demyelinating disorders
05/23/2001EP1100491A1 Ophthalmic compositions for treating ocular hypertension
05/23/2001CN1296010A Novel cyano-indole thrombotonin reuptaking inhibitor compound, its preparation process and medicinal compositions having the same
05/23/2001CN1066145C N-substituted 3-azabicyclo (3,2,0) heptane derivatives and preparing method and use thereof
05/22/2001US6235922 Processes and intermediates for preparing benzo-fused azepinone and piperidinone compounds useful in the inhibition of ACE and NEP
05/22/2001US6235731 Fused imidazopyridine derivatives as antihyperlipidemic agents
05/17/2001DE19954707A1 Imidazolverbindungen als Phosphodiesterase VII-Hemmer Imidazole compounds as phosphodiesterase VII inhibitor
05/17/2001DE19953454A1 Neue Thiophene und Verfahren zu ihrer Polymerisation New thiophenes and their methods of polymerization
05/16/2001EP1098891A1 Polycyclic thiazolidin-2-ylidene amines, method for the production and use thereof as medicaments
05/16/2001CN1295570A N-pyriconyl herbicides
05/15/2001US6232320 Cell adhesion-inhibiting antiinflammatory compounds
05/15/2001US6232310 Antidiabetic agents
05/10/2001WO2001032664A2 Novel thiophenes and method for polymerization of said thiophenes
05/10/2001WO2001032655A2 Quinoline and naphthyridine carboxylic acid antibacterials
05/09/2001EP1097920A1 Intermediate for condensed benzazepine derivatives
05/09/2001EP1097719A1 NEP inhibitors for the treatment of female sexual dysfunction
05/09/2001EP1097718A1 NPY antagonists for the treatment of female sexual dysfunction
05/09/2001EP1097707A1 Treatment of female sexual dysfunction
05/09/2001EP1097706A1 Phosphodiesterase inhibitors for the treatment of female sexual dysfunction
05/09/2001EP0693057B1 Process for the preparation of 4-(formylthio)-azetidin-2-one derivatives and penem derivatives
05/08/2001US6228869 Ortho-sulfonamido bicyclic hydroxamic acids as matrix metalloproteinase and TACE inhibitors
05/08/2001CA2324484A1 Compounds for the treatment of female sexual dysfunction
05/08/2001CA2323464A1 Compounds for the treatment of female sexual dysfunction
05/08/2001CA2323191A1 Compounds for the treatment of female sexual dysfunction
05/08/2001CA2323183A1 Compounds for the treatment of female sexual dysfunction
05/08/2001CA2045253C Dicarboximides
05/03/2001WO2001030781A2 INHIBITORS OF αLβ2 MEDIATED CELL ADHESION
05/02/2001EP1095275A2 Endogenous constitutively activated g protein-coupled orphan receptors
05/02/2001EP1095045A1 Method for producing anellated triazoles and new anellated triazoles and their use
05/02/2001EP1094810A1 Use of prenyltransferase inhibitors for preparing a medicine for treating pathologies resulting from heterotrimeric g protein membrane fixation
05/02/2001EP0988304B1 Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the dna polymerase of hepatitis b virus (hbv)
05/02/2001CN1293665A New compounds and their use as positive AMPA receptor modulators
05/02/2001CN1065245C Substituted tetracyclic oxazepine and thiazepine derivatives having effinity to 5-HT2 receptors
05/01/2001US6225330 For treatment of abnormal conditions such as feeding disorders (obesity and bulimia nervosa), sexual/reproductive disorders, depression, epileptic seizure, hypertension, cerebral hemorrhage, congestive heart failure, sleep disturbances
05/01/2001US6225310 Fused 1,2,4-thiadiazine derivatives, their preparation and use
05/01/2001US6225306 Pyrrolo(1,2a)quinoxalines
04/2001
04/26/2001WO2001029038A1 Tricyclic fused-imidazole derivatives
04/26/2001WO2001028992A2 New oxabispidine compounds useful in the treatment of cardiac arrhythmias
04/26/2001CA2386910A1 New oxabispidine compounds useful in the treatment of cardiac arrhythmias
04/25/2001EP1094066A2 Condensed heterocyclic glutamic acid derivatives as antiproliferative agents
04/25/2001EP1093372A1 CYCLIC AMINO ACID COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING $g(b)-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS
04/25/2001CN1064966C Condesned thiazole derivatives, having 5-HT receptor affinity
04/24/2001US6222040 Selective NPY (Y5) antagonists (tricyclics)
04/19/2001WO2001027119A2 Substance library containing bicyclic imidazo-5-yl-amines and/or bicyclic imidazo-3-yl-amines
04/19/2001WO2001027118A2 Bicyclic imidazo-5-yl-amine derivatives
04/19/2001WO2001027111A2 Bicyclic imidazo-3-yl-amine derivatives
04/19/2001WO2001027110A2 Bicyclic imidazo-3-yl-amine derivatives which are substituted on the sixth ring
04/19/2001WO2001027109A2 Tert.-butyl-(7-methyl-imidazo[1,2-a]pyridine-3-yl)-amine derivatives
04/19/2001WO2001027107A2 Heterocyclic sodium/proton exchange inhibitors and method
04/19/2001WO2001027087A2 Process for making boc-protected 3-aminohydantoins/thiohydantoins and 3-aminodihydrouracils/dihydrothiouracils
04/19/2001WO2001027084A1 Beta disubstituted metalloprotease inhibitors
04/19/2001US20010000344 N-(2-(R)-amino-3-mercaptopropyl)-L-penicillaminyl-1,2,3,4 -tetrahydro-3(S)-isoquinoline carbonyl methionine methylester cyclic disulfide, for example; administering as antitumor agent or to treat restenosis
04/19/2001CA2388813A1 Heterocyclic sodium/proton exchange inhibitors and method
04/19/2001CA2386804A1 Tert.-butyl-(7-methyl-imidazo[1,2-a]pyridine-3-yl)-amine derivatives
04/19/2001CA2386485A1 Beta disubstituted metalloprotease inhibitors
04/18/2001EP1092715A2 Cyano-indole derivatives as inhibitors of serotonin reuptake, method for their preparation and pharmaceutical compositions containing the same
04/18/2001EP1091960A1 Bifunctional antagonists of cytokine-sensitive protein kinase activation cascades and methods for use as anti-inflammatory agents
04/18/2001CN1291984A Glycine transport inhibitors
04/17/2001US6218408 Selective NPY (Y5) antagonists (bicyclics)
04/17/2001US6218072 Optical information recording medium
04/12/2001WO2001025242A1 Novel thiazolo(4,5-d)pyrimidine compounds
04/12/2001WO2001025241A2 Fused 1-(2,6-dichloro-4-trifluoromethylphenyl)-pyrazoles, the synthesis thereof and the use thereof as pesticides
04/12/2001WO2001025238A2 Heterocyclic compounds useful as inhibitors of tyrosine kinases
04/11/2001EP1090009A2 Cell adhesion-inhibiting antinflammatory compounds
04/11/2001EP1089989A1 Inhibitors of alpha4beta1 mediated cell adhesion
04/11/2001CN1291094A Bicyclic pyrrole derivatives as MCP-1 inhibitor
04/11/2001CN1064357C Novel antimicrobial 5-(N-heterosubstiluted amino) quinolones and medicinal composition